FDA Warns Against Using Smartwatches or Smart Rings for Blood Glucose Monitoring
View all alerts
Worst Pills, Best Pills

An expert, independent second opinion on more than 1,800 prescription drugs, over-the-counter medications, and supplements

fenfluramine (PONDIMIN)


DISEASE AND DRUG FAMILY INFORMATION

Search results below include Disease and Drug Family Information where your selected drug is a secondary subject of discussion.

Diet Drugs
The FDA has set the bar too low for the approval of diet drugs. Instead of requiring that diet drugs be proved to prevent the long term consequences of obesity (none ever has), diet drugs can be approved if they show a modest weight loss over a relatively short period.

DRUG AND DIETARY SUPPLEMENT PROFILES

A comprehensive review of the safety and effectiveness of this drug. If the drug is not a Do Not Use product, information on adverse effects, drug interactions and how to use the medication are included.
Search results below include Drug and Dietary Supplement Profiles where your selected drug is a secondary subject of discussion.

benzphetamine (DIDREX); diethylpropion (DURAD, TENUATE, TENUATE DOSPAN, TEPANIL); phendimetrazine (BONTRIL PDM, PLEGINE); phentermine (ADIPEX-P, ATTI PLEX P, FASTIN, IONAMIN, KRAFTOBESE, LOMAIRA, PANSHAPE M, PHENTERCOT, PHENTRIDE, PRO-FAST, RAPHTRE, SUPRAMINE, TARA-8, TERAMINE, TERMENE)
  • We list these drugs as Do Not Use drugs because they cause only very limited weight loss, are addictive and can cause central nervous system stimulation and high blood pressure.

WORST PILLS, BEST PILLS NEWSLETTER ARTICLES

Search results below include Worst Pills, Best Pills Newsletter Articles where your selected drug is a secondary subject of discussion.

Lorcaserin (BELVIQ): Another Do Not Use Diet Drug
March 2017
Learn about the unacceptable dangers posed by lorcaserin, a diet drug that was approved by the FDA in 2012 and that has similarities to the previously banned diet drug fenfluramine.
VYVANSE for Binge Eating: Old Pill, New ‘Disease’
September 2015
Don't fall prey to a drug company's slick marketing campaign of a dangerous drug recently approved by the FDA for treatment of a newly designated disease called "binge eating disorder."
When EMA and FDA Decisions Conflict: Differences in Patients or in Regulation?
December 2013
Are Americans more resistant to the risks and more likely to benefit from certain drugs than Europeans? Or is the European Medicines Agency (EMA) more resistant than the U.S. Food and Drug Administration (FDA) to the drug industry’s desire to get approval for drugs with unique risks but without compensating benefits? This article discusses two recently FDA-approved diet drugs deemed too unsafe for Europeans.
Troubling New Drug Approvals in 2012
March 2013
Find out which drugs approved in 2012 have risks greatly exceeding their benefits or no meaningful benefits. If you are using any of the DO NOT USE drugs reviewed in the article, talk to your doctor before stopping their use.
Update on Weight Loss Drug Sibutramine (MERIDIA)
July 2004
A new study shows that there is no direct evidence that sibutramine reduces obesity-associated morbidity or mortality and that there is insufficient evidence to accurately determine the risk-benefit profile for sibutramine.
New Warning! Heart Valve Damage With the Parkinson’s Disease Drug Pergolide (PERMAX)
April 2003
On February 24, 2003, Eli Lilly and Company of Indianapolis informed healthcare professionals that the professional product labeling, or “package insert,” for pergolide (PERMAX) was being updated to include a warning about the possibility of heart valve damage with the drug.

Show primary search results for fenfluramine (PONDIMIN)

Disclaimer

The information on this website is not intended to substitute for professional medical advice, diagnosis, or treatment. Consult your doctor before changing or discontinuing any medication.